Professor of Psychiatry, Stanford University, Stanford, California
Multiple forms of FDA-cleared neuromodulation treatments are readily available for patients with major depressive disorder (MDD). Dr. DeBattista will review the current status of neuromodulation devices used to treat resistant depression and consider the role of VNS, new forms of TMS, DBS and ECT.